Aerie pharmaceuticals announces u.s. food and drug administration approval of its athlone, ireland facility

Aerie pharmaceuticals announces u.s. food and drug administration approval of its athlone, ireland facility for production of rhopressa® (netarsudil ophthalmic solution) 0.02%.aerie pharmaceuticals announces u.s. food and drug administration approval of its athlone, ireland facility for production of rhopressa® (netarsudil ophthalmic solution) 0.02%.aerie pharmaceuticals inc - expect to begin shipping rhopressa to united states in q4 of 2020.
AERI Ratings Summary
AERI Quant Ranking